IL13RA2 and glioblastoma: Nevertheless, local delivery infusions of IL13Rα2-specific CAR T cells into a patient with recurrent GBM showed no toxic side effects and was associated with the regression of the primary as well as the metastatic spine tumors for 7.5 months.